Chemical Composition, Anti-α-Glucosidase Activity, and Molecular Modelling Studies of ICleistocalyx operculatus/I Essential Oil

In this study, chemical components, α-glucosidase inhibitory activities, and molecular modelling studies of the essential oil extracted from the Cleistocalyx operculatus leaves were investigated. In total, thirty compounds were identified using GC/MS, representing 98.3% of the oil. Of these, the two...

Full description

Saved in:
Bibliographic Details
Published inApplied sciences Vol. 13; no. 20
Main Authors Tran, Linh Thuy Thi, Nguyen, Tan Khanh, Pham, Ty Viet, Ha, Tran Phuong, Tran, Phan Thi Diem, Tam, Vu Thi Thanh, Dat, Ton That Huu, Thai, Pham Hong, Cuong, Le Canh Viet
Format Journal Article
LanguageEnglish
Published MDPI AG 01.10.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In this study, chemical components, α-glucosidase inhibitory activities, and molecular modelling studies of the essential oil extracted from the Cleistocalyx operculatus leaves were investigated. In total, thirty compounds were identified using GC/MS, representing 98.3% of the oil. Of these, the two most dominant constituents of the essential oil were determined as (Z)-β-ocimene (30.4%) and allo-ocimene (31.6%). The α-glucosidase inhibitory experiments indicated that the essential oil exhibited potent α-glucosidase inhibitory activities, with IC[sub.50] values of 61.82 ± 3.91 µg/mL. For further investigation into inhibitory mechanisms, molecular docking simulations were performed to investigate structural interactions between two dominant constituents and the α-glucosidase protein. The simulation revealed that allo-ocimene (31.6%) and (Z)-β-ocimene (30.4%) have protein binding affinities of −5.358 and −5.330 kcal/mol, respectively. Moreover, molecular dynamic simulation indicated that the complexes of two compounds and the target protein were stable over 100 ns. Overall, these findings suggest that the essential oil of C. operculatus leaves could be a natural source of potential α-glucosidase inhibitors.
ISSN:2076-3417
2076-3417
DOI:10.3390/app132011224